TrialJournal of the American Heart Association2018

Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.

Robert J Mentz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.